Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

58.09 -1.81 (-3.02%)

Streaming Delayed Price Updated: 12:54 PM EDT, Sep 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	229,453
Open	59.87
Bid (Size)	58.06 (400)
Ask (Size)	58.32 (100)
Prev. Close	59.90
Today's Range	56.93 - 59.95
52wk Range	14.27 - 66.37
Shares Outstanding	25,688,062
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

August 27, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript ↗

August 20, 2026

Revenue surged 99% year-over-year on HEMANGEOL relaunch and rare disease portfolio growth.

Via The Motley Fool

Performance

YTD	+257.3%	+257.3%
1 Month	+26.8%	+26.8%
3 Month	+101.0%	+101.0%
6 Month	+237.1%	+237.1%
1 Year	+232.9%	+232.9%

More News

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

August 14, 2026

Via Chartmill

Eton Pharmaceuticals (NASDAQ:ETON) Soars on Q1 Beat, Raises Full-Year Guidance ↗

May 14, 2026

Via Chartmill

Why Eton Pharmaceuticals Is Top of the Class Today ↗

August 14, 2026

Via The Motley Fool

Keep an eye on the top gainers and losers in Friday's session. ↗

August 14, 2026

Via Chartmill

Friday's session: gap up and gap down stocks ↗

August 14, 2026

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

August 14, 2026

Via Chartmill

Eton Pharmaceuticals Q2 Earnings Call Highlights ↗

August 13, 2026

Via MarketBeat

Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript ↗

August 13, 2026

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

August 13, 2026

Via Chartmill

Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results

August 13, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

August 05, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

August 03, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution

July 29, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)

May 19, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton (ETON) Q1 2026 Earnings Call Transcript ↗

May 15, 2026

Via The Motley Fool

Eton Pharmaceuticals Q1 Earnings Call Highlights ↗

May 14, 2026

Via MarketBeat

Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

May 14, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

May 12, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

May 04, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution

May 01, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700

April 27, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces CFO Succession Plan

April 16, 2026

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharma (ETON) Earnings Call Transcript ↗

March 19, 2026

Via The Motley Fool

Frequently Asked Questions

Is Eton Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Eton Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Eton Pharmaceuticals, Inc. - Common Stock trade on?

Eton Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock is ETON on the Nasdaq Stock Market

What is the current price of Eton Pharmaceuticals, Inc. - Common Stock?

The current price of Eton Pharmaceuticals, Inc. - Common Stock is 58.09

When was Eton Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Eton Pharmaceuticals, Inc. - Common Stock was at 09/04/26 12:54 PM ET

What is the market capitalization of Eton Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Eton Pharmaceuticals, Inc. - Common Stock is 1.49B

How many shares of Eton Pharmaceuticals, Inc. - Common Stock are outstanding?

Eton Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.